Juliane Traxler, Catharina C Braren-von Stülpnagel, Matthias Augustin, Marius Grosser, Dennis Roggenkamp, Rachel Sommer
Background and objectives: People with skin disease often experience stigmatization in health and body care settings, significantly impacting their quality of life. This parallel-group randomized controlled trial evaluated a face-to-face group seminar aimed at reducing stigma towards people with skin disease among health and body care professionals (HBCPs).
Patients and methods: Cosmetologists, hairdressers, nurses, and physical therapists were randomized into an intervention (IG; n = 64) or control group (CG; n = 65). The IG received a seminar consisting of self-awareness exercises, education and a patient encounter; the CG followed a seminar on "health at work". Stereotype agreement, disease-related misconceptions, desire for social distance, and behavioral intentions were assessed at baseline (t0), post-intervention (t1), and 3 months follow-up (t2).
Results: The intervention group showed significant reductions over time in disease-related misconceptions (t0-t1: 0.398, p < 0.001; t0-t2: 0.225, p < 0.001; ηp2 = 0.12) and in stereotype endorsement (t0-t1: 0.392, p < 0.001; t0-t2: 0.299, p = 0.002; ηp2 = 0.12). In both groups, the desire for social distance decreased immediately after the seminar (t0-t1Intervention: 0.186, p < 0.001; t0-t1Control: 0.135, p = 0.012) but returned to baseline at follow-up (t0-t2Intervention: 0.097, p = 0.35; t0-t2Control: 0.016, p = 1.00).
Conclusions: The seminar improved skin disease-related stigmatizing beliefs and attitudes of HBCPs. Its integration into vocational training curricula or delivery in workshops to increase knowledge about skin diseases and to reduce prejudices in various professional groups is promising.
背景和目的：皮肤病患者经常在卫生和身体护理机构受到歧视，严重影响了他们的生活质量。这项平行组随机对照试验评估了一个面对面的小组研讨会，旨在减少健康和身体护理专业人员（HBCPs）对皮肤病患者的耻辱感。患者和方法：美容师、美发师、护士和物理治疗师随机分为干预组（IG, n = 64）和对照组（CG, n = 65）。总检察长参加了一个研讨会，内容包括自我意识练习、教育和与病人会面；政府首脑在“工作中的健康”研讨会之后举行。在基线(0)、干预后（t1）和3个月随访（t2）时评估刻板印象一致性、疾病相关误解、对社会距离的渴望和行为意图。结果：干预组在疾病相关误解（t0-t1: 0.398, p 2 = 0.12）和刻板印象认同（t0-t1: 0.392, p 2 = 0.12）方面随时间显著降低。在两组中，对社交距离的渴望在研讨会结束后立即下降（干预期：0.186，p对照组：0.135,p = 0.012），但在随访时又恢复到基线（干预期：0.097,p = 0.35；对照组：0.016,p = 1.00）。结论：研讨会改善了hbcp与皮肤病相关的污名化信念和态度。将其纳入职业培训课程或在讲习班中提供，以增加有关皮肤病的知识并减少各种专业群体中的偏见，这是有希望的。
{"title":"Efficacy of an intervention to reduce stigma towards people with skin diseases among health and body care professionals - a randomized controlled trial.","authors":"Juliane Traxler, Catharina C Braren-von Stülpnagel, Matthias Augustin, Marius Grosser, Dennis Roggenkamp, Rachel Sommer","doi":"10.1111/ddg.16017","DOIUrl":"https://doi.org/10.1111/ddg.16017","url":null,"abstract":"<p><strong>Background and objectives: </strong>People with skin disease often experience stigmatization in health and body care settings, significantly impacting their quality of life. This parallel-group randomized controlled trial evaluated a face-to-face group seminar aimed at reducing stigma towards people with skin disease among health and body care professionals (HBCPs).</p><p><strong>Patients and methods: </strong>Cosmetologists, hairdressers, nurses, and physical therapists were randomized into an intervention (IG; n = 64) or control group (CG; n = 65). The IG received a seminar consisting of self-awareness exercises, education and a patient encounter; the CG followed a seminar on \"health at work\". Stereotype agreement, disease-related misconceptions, desire for social distance, and behavioral intentions were assessed at baseline (t0), post-intervention (t1), and 3 months follow-up (t2).</p><p><strong>Results: </strong>The intervention group showed significant reductions over time in disease-related misconceptions (t0-t1: 0.398, p < 0.001; t0-t2: 0.225, p < 0.001; ηp<sup>2</sup> = 0.12) and in stereotype endorsement (t0-t1: 0.392, p < 0.001; t0-t2: 0.299, p = 0.002; ηp<sup>2</sup> = 0.12). In both groups, the desire for social distance decreased immediately after the seminar (t0-t1<sub>Intervention</sub>: 0.186, p < 0.001; t0-t1<sub>Control</sub>: 0.135, p = 0.012) but returned to baseline at follow-up (t0-t2<sub>Intervention</sub>: 0.097, p = 0.35; t0-t2<sub>Control</sub>: 0.016, p = 1.00).</p><p><strong>Conclusions: </strong>The seminar improved skin disease-related stigmatizing beliefs and attitudes of HBCPs. Its integration into vocational training curricula or delivery in workshops to increase knowledge about skin diseases and to reduce prejudices in various professional groups is promising.</p>","PeriodicalId":14758,"journal":{"name":"Journal Der Deutschen Dermatologischen Gesellschaft","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145989210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Marie Sander, Matthias Augustin, Valerie Andrees, Sandra Hischke, Jobst Augustin
Background and objectives: Prevalence rates of atopic diseases (atopic dermatitis [AD], allergic asthma [AA], and allergic rhinoconjunctivitis [ARC]) have increased in Germany. However, there is a lack of simultaneous consideration and of precise data on the spatiotemporal variation of these diseases. This study investigates the spatiotemporal variation of atopic diseases in Germany.
Methods: Analyses based on outpatient care data (2011-2020) of all statutory health insured persons in Germany. Spatiotemporal analyses of prevalence rates were performed on county levels and statistical smoothing were applied.
Results: Prevalence rates increased for all three diseases. Moderate but significant (p < 0.05) correlations were among others observed between ARC and AA (r = 0.47). Correlations with the east-west gradient were significant for all diseases, meaning higher prevalence rates of AD in the east and higher prevalence rates of AA and ARC in the west. The correlation coefficients showed significant values between the north-south gradient and AD, as well as between the north-south gradient and AA, implying higher prevalences in northern Germany.
Conclusions: Prevalence rates for atopic diseases have increased over the past decade. Regional patterns are different for AD and the other atopic diseases. The reasons for the increase and the variations need to be analysed in detail with a view to improving prevention and health care.
{"title":"Regional variations and temporal trends of atopic diseases in Germany.","authors":"Marie Sander, Matthias Augustin, Valerie Andrees, Sandra Hischke, Jobst Augustin","doi":"10.1111/ddg.15926","DOIUrl":"https://doi.org/10.1111/ddg.15926","url":null,"abstract":"<p><strong>Background and objectives: </strong>Prevalence rates of atopic diseases (atopic dermatitis [AD], allergic asthma [AA], and allergic rhinoconjunctivitis [ARC]) have increased in Germany. However, there is a lack of simultaneous consideration and of precise data on the spatiotemporal variation of these diseases. This study investigates the spatiotemporal variation of atopic diseases in Germany.</p><p><strong>Methods: </strong>Analyses based on outpatient care data (2011-2020) of all statutory health insured persons in Germany. Spatiotemporal analyses of prevalence rates were performed on county levels and statistical smoothing were applied.</p><p><strong>Results: </strong>Prevalence rates increased for all three diseases. Moderate but significant (p < 0.05) correlations were among others observed between ARC and AA (r = 0.47). Correlations with the east-west gradient were significant for all diseases, meaning higher prevalence rates of AD in the east and higher prevalence rates of AA and ARC in the west. The correlation coefficients showed significant values between the north-south gradient and AD, as well as between the north-south gradient and AA, implying higher prevalences in northern Germany.</p><p><strong>Conclusions: </strong>Prevalence rates for atopic diseases have increased over the past decade. Regional patterns are different for AD and the other atopic diseases. The reasons for the increase and the variations need to be analysed in detail with a view to improving prevention and health care.</p>","PeriodicalId":14758,"journal":{"name":"Journal Der Deutschen Dermatologischen Gesellschaft","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145989177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Huizhong Wang, Shanshan Li, Yujie Wen, Zhuojing Chen, Beini Lyu, Yang Wang, Jingru Sun
{"title":"Bakterielle Hautkolonisation und systemische Antibiotikatherapie bei Patienten mit kutanem T-Zell-Lymphom","authors":"Huizhong Wang, Shanshan Li, Yujie Wen, Zhuojing Chen, Beini Lyu, Yang Wang, Jingru Sun","doi":"10.1111/ddg.15865_g","DOIUrl":"https://doi.org/10.1111/ddg.15865_g","url":null,"abstract":"","PeriodicalId":14758,"journal":{"name":"Journal Der Deutschen Dermatologischen Gesellschaft","volume":"24 1","pages":"65-75"},"PeriodicalIF":3.8,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145983782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Remission der erythropoetischen Protoporphyrie (EPP) während der Schwangerschaft – Erfahrungen von zwei Patientinnen","authors":"Paul Gressenberger, Angelika Hofer","doi":"10.1111/ddg.15843_g","DOIUrl":"https://doi.org/10.1111/ddg.15843_g","url":null,"abstract":"","PeriodicalId":14758,"journal":{"name":"Journal Der Deutschen Dermatologischen Gesellschaft","volume":"24 1","pages":"79-80"},"PeriodicalIF":3.8,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145983863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sven-Niklas Burmann, Thilo Gambichler, Jürgen C. Becker, Frank Oellig, Alexander Kreuter, Ulrich Peter Wehry
{"title":"Leucaemia cutis bei Acrodermatitis chronica atrophicans und chronischer lymphatischer B-Zell-Leukämie: Komplette Abheilung unter Doxycyclin","authors":"Sven-Niklas Burmann, Thilo Gambichler, Jürgen C. Becker, Frank Oellig, Alexander Kreuter, Ulrich Peter Wehry","doi":"10.1111/ddg.15868_g","DOIUrl":"https://doi.org/10.1111/ddg.15868_g","url":null,"abstract":"","PeriodicalId":14758,"journal":{"name":"Journal Der Deutschen Dermatologischen Gesellschaft","volume":"24 1","pages":"98-101"},"PeriodicalIF":3.8,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145993919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tabael L. Turan, Thomas K. Eigentler, Ulrike Blume-Peytavi, Kamran Ghoreschi
<p>Sehr geehrte Herausgeber,</p><p>Patienten mit malignen hämatologischen Erkrankungen sind einem signifikant erhöhten Risiko ausgesetzt, einen Herpes zoster (HZ) zu entwickeln, also eine Reaktivierung latenter Varizella-Zoster-Viren (VZV). Potenziell tödliche HZ-bedingte Komplikationen wie systemische VZV-Dissemination treten bei diesen Patienten häufiger auf.<span><sup>1, 2</sup></span> Bei Patienten mit chronischer lymphatischer Leukämie (CLL) sind sowohl die Erkrankung selbst als auch die vorgenommene Behandlung für eine fehlregulierte Immunantwort verantwortlich. Solche Patienten sind anfällig für Infektionen und Komplikationen, insbesondere in den ersten Jahren nach Diagnosestellung.<span><sup>3, 4</sup></span> Die frühzeitige Einleitung wirksamer antiviraler Medikamente ist beim HZ prognostisch entscheidend, wobei intravenöses Aciclovir (ACV) das Mittel der Wahl ist.<span><sup>5</sup></span> Resistenzen von VZV auf ACV wurden vorrangig bei immundefizienten Patienten beschrieben und beruhen üblicherweise auf Mutationen des viralen Thymidinkinase (TK)-Gens.<span><sup>6</sup></span> Thymidinkinase-unabhängige Zweitlinientherapien mit Virostatika wie Foscarnet (FOS) oder Cidofovir haben sich in solchen Fällen vereinzelt als wirksam erwiesen.<span><sup>7, 8</sup></span> Hier berichten wir über den Fall einer Patientin mit chronischer lymphatischer B-Zell-Leukämie (B-CLL) unter abwartendem Beobachten, die trotz langfristiger antiviraler Therapie mit ACV und FOS einen progressiven, disseminierten HZ mit Lungenbeteiligung entwickelte.</p><p>Eine 60-jährige Frau stellte sich im Juli 2024 in der Notaufnahme mit einer seit zwei Tagen bestehenden, schmerzhaften vesikulären Eruption vor, welche das Dermatom V1 links betraf. Die Patientin berichtete, dass dem Ausschlag ein dreitägiges lokales Kribbeln vorausgegangen sei. Die Patientin gab keine anderen Symptome an, wie zum Beispiel Sehstörungen, und verneinte, in der Vergangenheit einen ähnlichen Ausschlag gehabt zu haben. Sie hatte zuvor noch keine HZ-Impfung erhalten. Aus der Anamnese ging hervor, dass bei ihr im Jahre 2013 eine B-CLL [del(13q)] diagnostiziert worden war, für die sie 2015/16 sechs Zyklen einer Erstlinien-Chemoimmuntherapie mit Bendamustin plus Rituximab erhalten hatte, gefolgt von abwartendem Beobachten. Zwanzig Tage vor Aufnahme wurden im Rahmen der Nachsorge im Blut Leukozyten (<i>white blood cell</i>, WBC) von 49,8 × 10<sup>3</sup>/µl und ein normwertiges C-reaktives Protein (CRP) gemessen. Zu diesem Zeitpunkt lag keine Hypogammaglobulinämie vor (IgG: 11,93 g/l).</p><p>Bei der körperlichen Untersuchung ließen sich etwa 25 Vesikel außerhalb des primär befallenen Dermatoms finden, welche die Nackenregion, den vorderen Rumpf sowie die oberen Extremitäten betrafen. Mit Ausnahme eines moderaten ipsilateralen Lidödems wurden keine okulären Manifestationen festgestellt. Ebenso war keine Lymphadenopathie palpabel. Die Blutentnahme ergab eine erhöhte CRP-Konzentration (81,3 mg/l) und eine r
{"title":"Aciclovir-resistenter Zoster disseminatus bei chronischer lymphatischer B-Zell-Leukämie","authors":"Tabael L. Turan, Thomas K. Eigentler, Ulrike Blume-Peytavi, Kamran Ghoreschi","doi":"10.1111/ddg.15870_g","DOIUrl":"https://doi.org/10.1111/ddg.15870_g","url":null,"abstract":"<p>Sehr geehrte Herausgeber,</p><p>Patienten mit malignen hämatologischen Erkrankungen sind einem signifikant erhöhten Risiko ausgesetzt, einen Herpes zoster (HZ) zu entwickeln, also eine Reaktivierung latenter Varizella-Zoster-Viren (VZV). Potenziell tödliche HZ-bedingte Komplikationen wie systemische VZV-Dissemination treten bei diesen Patienten häufiger auf.<span><sup>1, 2</sup></span> Bei Patienten mit chronischer lymphatischer Leukämie (CLL) sind sowohl die Erkrankung selbst als auch die vorgenommene Behandlung für eine fehlregulierte Immunantwort verantwortlich. Solche Patienten sind anfällig für Infektionen und Komplikationen, insbesondere in den ersten Jahren nach Diagnosestellung.<span><sup>3, 4</sup></span> Die frühzeitige Einleitung wirksamer antiviraler Medikamente ist beim HZ prognostisch entscheidend, wobei intravenöses Aciclovir (ACV) das Mittel der Wahl ist.<span><sup>5</sup></span> Resistenzen von VZV auf ACV wurden vorrangig bei immundefizienten Patienten beschrieben und beruhen üblicherweise auf Mutationen des viralen Thymidinkinase (TK)-Gens.<span><sup>6</sup></span> Thymidinkinase-unabhängige Zweitlinientherapien mit Virostatika wie Foscarnet (FOS) oder Cidofovir haben sich in solchen Fällen vereinzelt als wirksam erwiesen.<span><sup>7, 8</sup></span> Hier berichten wir über den Fall einer Patientin mit chronischer lymphatischer B-Zell-Leukämie (B-CLL) unter abwartendem Beobachten, die trotz langfristiger antiviraler Therapie mit ACV und FOS einen progressiven, disseminierten HZ mit Lungenbeteiligung entwickelte.</p><p>Eine 60-jährige Frau stellte sich im Juli 2024 in der Notaufnahme mit einer seit zwei Tagen bestehenden, schmerzhaften vesikulären Eruption vor, welche das Dermatom V1 links betraf. Die Patientin berichtete, dass dem Ausschlag ein dreitägiges lokales Kribbeln vorausgegangen sei. Die Patientin gab keine anderen Symptome an, wie zum Beispiel Sehstörungen, und verneinte, in der Vergangenheit einen ähnlichen Ausschlag gehabt zu haben. Sie hatte zuvor noch keine HZ-Impfung erhalten. Aus der Anamnese ging hervor, dass bei ihr im Jahre 2013 eine B-CLL [del(13q)] diagnostiziert worden war, für die sie 2015/16 sechs Zyklen einer Erstlinien-Chemoimmuntherapie mit Bendamustin plus Rituximab erhalten hatte, gefolgt von abwartendem Beobachten. Zwanzig Tage vor Aufnahme wurden im Rahmen der Nachsorge im Blut Leukozyten (<i>white blood cell</i>, WBC) von 49,8 × 10<sup>3</sup>/µl und ein normwertiges C-reaktives Protein (CRP) gemessen. Zu diesem Zeitpunkt lag keine Hypogammaglobulinämie vor (IgG: 11,93 g/l).</p><p>Bei der körperlichen Untersuchung ließen sich etwa 25 Vesikel außerhalb des primär befallenen Dermatoms finden, welche die Nackenregion, den vorderen Rumpf sowie die oberen Extremitäten betrafen. Mit Ausnahme eines moderaten ipsilateralen Lidödems wurden keine okulären Manifestationen festgestellt. Ebenso war keine Lymphadenopathie palpabel. Die Blutentnahme ergab eine erhöhte CRP-Konzentration (81,3 mg/l) und eine r","PeriodicalId":14758,"journal":{"name":"Journal Der Deutschen Dermatologischen Gesellschaft","volume":"24 1","pages":"87-90"},"PeriodicalIF":3.8,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ddg.15870_g","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145969874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Vollständige Rekonstruktion der Ohrmuschel und ausgedehnte retroaurikuläre Reparatur","authors":"Igor Kapetanovic, Adam Mattox, Ian Maher","doi":"10.1111/ddg.15840_g","DOIUrl":"https://doi.org/10.1111/ddg.15840_g","url":null,"abstract":"","PeriodicalId":14758,"journal":{"name":"Journal Der Deutschen Dermatologischen Gesellschaft","volume":"24 1","pages":"117-120"},"PeriodicalIF":3.8,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145964412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Angriff aus dem Boden in 1560 m Höhe: Tinea corporis durch Nannizzia fulva","authors":"Veronika Batzill, Marie-Charlotte Brüggen, Matthias Möhrenschlager","doi":"10.1111/ddg.15871_g","DOIUrl":"https://doi.org/10.1111/ddg.15871_g","url":null,"abstract":"","PeriodicalId":14758,"journal":{"name":"Journal Der Deutschen Dermatologischen Gesellschaft","volume":"24 1","pages":"102-103"},"PeriodicalIF":3.8,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145983540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Journal-Club","authors":"Konstantin Drexler","doi":"10.1111/ddg.70034","DOIUrl":"https://doi.org/10.1111/ddg.70034","url":null,"abstract":"","PeriodicalId":14758,"journal":{"name":"Journal Der Deutschen Dermatologischen Gesellschaft","volume":"24 1","pages":"142-143"},"PeriodicalIF":3.8,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145963793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Nachruf auf Prof. Dr. med. Maurizio Podda","authors":"Roland Kaufmann, Christoph R. Löser","doi":"10.1111/ddg.70032","DOIUrl":"https://doi.org/10.1111/ddg.70032","url":null,"abstract":"","PeriodicalId":14758,"journal":{"name":"Journal Der Deutschen Dermatologischen Gesellschaft","volume":"24 1","pages":"144-145"},"PeriodicalIF":3.8,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145964151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号